Tumour necrosis factor blockade mediates altered serotonin transporter availability in rheumatoid arthritis: a clinical, proof-of-concept study.

Tumour necrosis factor blockade mediates altered serotonin transporter availability in rheumatoid arthritis: a clinical, proof-of-concept study.

Item
http://www.wikidata.org/entity/Q43108123
Sustained remission of rheumatoid arthritis with a specific serotonin reuptake inhibitor antidepressant: a case report and review of the literatureImmune-to-Brain Communication Pathways in Inflammation-Associated Sickness and Depression.Cardio-metabolic risk factors and cortical thickness in a neurologically healthy male population: Results from the psychological, social and biological determinants of ill health (pSoBid) study.Consequences of cancer treatments on adult hippocampal neurogenesis: implications for cognitive function and depressive symptomsThe temporal relationship between depression and rheumatoid arthritis disease activity, treatment persistence and response: a systematic review.Human immunodeficiency virus-associated depression: contributions of immuno-inflammatory, monoaminergic, neurodegenerative, and neurotrophic pathways.Anti-inflammatory treatment for major depressive disorder: implications for patients with an elevated immune profile and non-responders to standard antidepressant therapy.Association of brain functional magnetic resonance activity with response to tumor necrosis factor inhibition in rheumatoid arthritis.Improvements in patient-reported outcomes, symptoms of depression and anxiety, and their association with clinical remission among patients with moderate-to-severe active early rheumatoid arthritis.Therapeutic strategies for treatment of inflammation-related depression.Sleep quality in patients with Behçet's disease.Temporal associations between the different domains of rheumatoid arthritis disease activity and the onset of patient-reported depressive symptoms.Mental health, fatigue and function are associated with increased risk of disease flare following TNF inhibitor tapering in patients with rheumatoid arthritis: an exploratory analysis of data from the Optimizing TNF Tapering in RA (OPTTIRA) trial.
P2860

Tumour necrosis factor blockade mediates altered serotonin transporter availability in rheumatoid arthritis: a clinical, proof-of-concept study.

Item
http://www.wikidata.org/entity/Q43108123
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Tumour necrosis factor blockad ...... nical, proof-of-concept study.
@en
Tumour necrosis factor blockad ...... nical, proof-of-concept study.
@nl
type
label
Tumour necrosis factor blockad ...... nical, proof-of-concept study.
@en
Tumour necrosis factor blockad ...... nical, proof-of-concept study.
@nl
prefLabel
Tumour necrosis factor blockad ...... nical, proof-of-concept study.
@en
Tumour necrosis factor blockad ...... nical, proof-of-concept study.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Tumour necrosis factor blockad ...... nical, proof-of-concept study.
@en
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921